A detailed history of First Financial Corp transactions in Astrazeneca PLC stock. As of the latest transaction made, First Financial Corp holds 17 shares of AZN stock, worth $1,110. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17
Previous 75 77.33%
Holding current value
$1,110
Previous $5,000 80.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$76.67 - $87.62 $4,446 - $5,081
-58 Reduced 77.33%
17 $1,000
Q2 2024

Jul 11, 2024

SELL
$66.81 - $80.83 $17,303 - $20,934
-259 Reduced 77.54%
75 $5,000
Q1 2024

Apr 12, 2024

SELL
$61.03 - $69.57 $89,103 - $101,572
-1,460 Reduced 81.38%
334 $22,000
Q3 2022

Oct 20, 2022

BUY
$53.02 - $135.75 $1,802 - $4,615
34 Added 1.93%
1,794 $98,000
Q3 2017

Oct 13, 2017

BUY
$28.96 - $34.0 $50,969 - $59,840
1,760
1,760 $60,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $203B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track First Financial Corp Portfolio

Follow First Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Financial Corp , based on Form 13F filings with the SEC.

News

Stay updated on First Financial Corp with notifications on news.